Michel, Martin C.

How reliable are G-protein-coupled receptor antibodies?

Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology

Receptor Mechanisms and SignalingMonoclonal and Polyclonal Antibodies Research

Cited by 306

Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors

Pradidarcheep, W., Stallen, J., Labruyère, W. T., Dabhoiwala, N. F., Michel, M. C., & Lamers, W. H. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology

Receptor Mechanisms and SignalingMonoclonal and Polyclonal Antibodies Research

Cited by 152

New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

Michel, M. C., Murphy, T. J., & Motulsky, H. J. (2020) · Molecular Pharmacology

Academic Writing and PublishingAcademic Publishing and Open Access

Cited by 127

Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study

Ruhé, H. G., Booij, J., Veltman, D. J., Michel, M. C., & Schene, A. H. (2012) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 104

Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

Ruhé, H. G., Booij, J., Weert, H. C. V., Reitsma, J. B., Fransen, E. J. F., Michel, M. C., & Schene, A. H. (2009) · Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 73